Moderna on April 28 said it has asked the U.S. Food and Drug Administration (FDA) to grant emergency use authorization (EUA) to the company for its COVID-19 vaccine for children as young as 6 months.
The EUA submission is for two 25-microgram doses of the shot, mRNA-1273, in children 6 months old to 5 years old.
